BRCA1 and breast carcinoma: Recent studies have shown an increase in the diagnosis of hereditary breast cancer with the use of multigene panels compared to the restricted gene panel, and guidelines now recommend genetic testing for all patients with breast cancer as well as multigene testing for those with negative BRCA1/2 testing [5].